Skip to main content

and
  1. No Access

    Article

    Transcutaneous electrical acupoint stimulation for cancer-related pain management in patients receiving chronic opioid therapy: a randomized clinical trial

    The opioid crisis resulting from its use disorder and overdose poses additional challenges for cancer pain management. The American Society of Clinical Oncology Practice Guideline recommends acupuncture therap...

    Zhengyi Lyu, Shuxin Tian, Guanai Bao, Rui Huang, Liyan Gong in Supportive Care in Cancer (2023)

  2. Article

    Open Access

    Pegylated liposomal doxorubicin (Duomeisu®) monotherapy in patients with HER2-negative metastatic breast cancer heavily pretreated with anthracycline and taxanes: a single-arm, phase II study

    To evaluate the efficacy and safety of pegylated liposomal doxorubicin (PLD) in patients with human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC) heavily pretreated with ant...

    Hanfang Jiang, Hui** Li, Guohong Song, Lijun Di in Breast Cancer Research and Treatment (2023)

  3. Article

    Open Access

    Activity of preclinical and phase I clinical trial of a novel androgen receptor antagonist GT0918 in metastatic breast cancer

    To evaluate GT0918, a 2nd-generation AR antagonist, for its AR down-regulation activity among breast cancer patients.

    Hui** Li, Guohong Song, Qiaoxia Zhou, Ran Ran in Breast Cancer Research and Treatment (2021)

  4. Article

    Open Access

    A role for CBFβ in maintaining the metastatic phenotype of breast cancer cells

    Epithelial to mesenchymal transition (EMT) is a dynamic process that drives cancer cell plasticity and is thought to play a major role in metastasis. Here we show, using MDA-MB-231 cells as a model, that the p...

    Ran Ran, Hannah Harrison, Nur Syamimi Ariffin, Rahna Ayub, Henry J. Pegg in Oncogene (2020)

  5. No Access

    Article

    Prognostic and clinicopathological value of PD-L1 expression in primary breast cancer: a meta-analysis

    To evaluate the association between PD-L1 expression (PD-L1+) and clinicopathological characteristics and effect on prognosis in primary breast cancer (PBC).

    Wenfa Huang, Ran Ran, Bin Shao, Hui** Li in Breast Cancer Research and Treatment (2019)